Sort
17,288 grants matching “multiple sclerosis”
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial
$512,276Marisa McGinley · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NR
RNA-based regulation of TDP-43 nuclear export in ALS/FTD
$511,899Lindsey Renae Hayes · Johns Hopkins University · R01 · FY2022 · NS
Genome-Wide Association Studies of Diabetic Nephropathy
$511,768Joel N Hirschhorn · Broad Institute, Inc. · R01 · FY2012 · DK
4 TELSA MRI BOLUS CR STUDIES OF HUMAN BBB PERMEABILITY
$511,768Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2001 · NS
Regulatory T cells in allogeneic transplantation
$511,595Robert S Negrin · Stanford University · R01 · FY2014 · HL
Repurposing esomeprazole for the treatment of scleroderma
$511,584Yohannes T Ghebre · University Of Texas Hlth Science Center · R01 · FY2025 · AR
Post GWAS approach to identify cell-specific genetic pathways underlying MS risk
$511,329Sergio E Baranzini · University Of California, San Francisco · R01 · FY2015 · NS
Determining How Defective Nucleo-Cytoplasmic Trafficking Leads To Neurodegeneration In C9orf72-Related ALS And FTD
$511,285Evangelos Kiskinis · Northwestern University At Chicago · R01 · FY2020 · NS
Oligodendrocyte damage and dysfunction in HIV associated neurocognitive disorder
$511,268Kelly L Jordan-Sciutto · University Of Pennsylvania · R01 · FY2013 · MH
Imaging and computational platform for integrated analysis of biodata
$511,011Alon Greenbaum · North Carolina State University Raleigh · R01 · FY2025 · NS
Human Herpesvirus 6B in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome pathogenesis: temporal analysis of viral reactivation and immunity to elucidate cause vs effect
$510,930Eliana Lacerda · London Sch/Hygiene & Tropical Medicine · R01 · FY2024 · AI
Clinical and Economic Impact of Teleneurology vs Standard in Clinic Care for Multiple Sclerosis: A Randomized Trial
$510,900Marisa McGinley · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · NR
Preclinical models, biomarkers, and therapy for myotonic dystrophy type 1
$510,858Maurice S Swanson · University Of Rochester · P50 · FY2020 · NS
Resource for Nonhuman Primate Immune Reagents
$510,411Francois J Villinger · Emory University · R24 · FY2011 · RR
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2020 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2022 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2019 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2021 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2023 · AI
Optimization of ultrasound-facilitated blood-brain barrier opening
$509,992Elisa E Konofagou · Columbia Univ New York Morningside · R01 · FY2010 · EB
Blood-Brain Barrier Deficit and Brain Injury in Obstructive Sleep Apnea
$509,983Rajesh Kumar · University Of California Los Angeles · R01 · FY2017 · NR
Blood-Brain Barrier Deficit and Brain Injury in Obstructive Sleep Apnea
$509,978Rajesh Kumar · University Of California Los Angeles · R01 · FY2015 · NR
Neurofilaments, SOD1 and Motor Neuron Diseases
$509,861Ludwig Institute For Cancer Research · R01 · FY2003 · NS
In vivo MRI Biomarkers of Microstructural Correlates of Brain Pathology in Preclinical and Early Alzheimer Disease
$509,695Dmitriy A Yablonskiy · Washington University · R01 · FY2017 · AG
The curious case of PARP1 in CNS myelin formation and repair
$509,373Fuzheng Guo · University Of California At Davis · R01 · FY2025 · NS